Cargando…
Use of Vivostat PRF® in Acanthamoeba keratitis
We present a case of a 27-year-old contact lens male user who was diagnosed with Acanthamoeba keratitis. Given the inefficiency of medical treatment and high risk of corneal perforation, we decided to use Vivostat PRF®, with satisfactory results. To our knowledge, this is the first described case in...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Romanian Society of Ophthalmology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339696/ https://www.ncbi.nlm.nih.gov/pubmed/32685791 |
_version_ | 1783554936098783232 |
---|---|
author | Marín-Payá, Emma Rahhal-Ortuño, Miriam Aguilar-González, Marina Fernández-Santodomingo, Alex Samir García-Delpech, Salvador |
author_facet | Marín-Payá, Emma Rahhal-Ortuño, Miriam Aguilar-González, Marina Fernández-Santodomingo, Alex Samir García-Delpech, Salvador |
author_sort | Marín-Payá, Emma |
collection | PubMed |
description | We present a case of a 27-year-old contact lens male user who was diagnosed with Acanthamoeba keratitis. Given the inefficiency of medical treatment and high risk of corneal perforation, we decided to use Vivostat PRF®, with satisfactory results. To our knowledge, this is the first described case in medical literature in which Vivostat PRF® is used as part of Acanthamoeba keratitis treatment. |
format | Online Article Text |
id | pubmed-7339696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Romanian Society of Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-73396962020-07-17 Use of Vivostat PRF® in Acanthamoeba keratitis Marín-Payá, Emma Rahhal-Ortuño, Miriam Aguilar-González, Marina Fernández-Santodomingo, Alex Samir García-Delpech, Salvador Rom J Ophthalmol Case Reports We present a case of a 27-year-old contact lens male user who was diagnosed with Acanthamoeba keratitis. Given the inefficiency of medical treatment and high risk of corneal perforation, we decided to use Vivostat PRF®, with satisfactory results. To our knowledge, this is the first described case in medical literature in which Vivostat PRF® is used as part of Acanthamoeba keratitis treatment. Romanian Society of Ophthalmology 2020 /pmc/articles/PMC7339696/ /pubmed/32685791 Text en ©Romanian Society of Ophthalmology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Marín-Payá, Emma Rahhal-Ortuño, Miriam Aguilar-González, Marina Fernández-Santodomingo, Alex Samir García-Delpech, Salvador Use of Vivostat PRF® in Acanthamoeba keratitis |
title | Use of Vivostat PRF® in Acanthamoeba keratitis
|
title_full | Use of Vivostat PRF® in Acanthamoeba keratitis
|
title_fullStr | Use of Vivostat PRF® in Acanthamoeba keratitis
|
title_full_unstemmed | Use of Vivostat PRF® in Acanthamoeba keratitis
|
title_short | Use of Vivostat PRF® in Acanthamoeba keratitis
|
title_sort | use of vivostat prf® in acanthamoeba keratitis |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339696/ https://www.ncbi.nlm.nih.gov/pubmed/32685791 |
work_keys_str_mv | AT marinpayaemma useofvivostatprfinacanthamoebakeratitis AT rahhalortunomiriam useofvivostatprfinacanthamoebakeratitis AT aguilargonzalezmarina useofvivostatprfinacanthamoebakeratitis AT fernandezsantodomingoalexsamir useofvivostatprfinacanthamoebakeratitis AT garciadelpechsalvador useofvivostatprfinacanthamoebakeratitis |